Global CRDMO positioning CPC Scientific operates as a globally recognized CRDMO with expertise in synthetic GMP peptides, oligonucleotides, and peptide-oligonucleotide conjugates, offering end-to-end support from discovery to commercial production. This presents sales opportunities with biotech and pharma partners needing integrated development, scale-up, and regulatory support for IND/NDA/BLA filings across US and international markets.

Late-stage focus The company emphasizes late-phase development and large-scale manufacturing, aligning with sponsors aiming to de-risk transitions to commercialization. Target opportunities include programs nearing IND/NDA timelines, where CPC Scientific can accelerate timelines, provide GMP manufacturing capacity, and ensure regulatory-compliant process validation and stability studies.

Capacity and agility CPC Scientific highlights flexible capacity and rapid project onboarding, with a dedicated US facility in Rocklin and a robust supply chain. This supports sales conversations with sponsors facing tight delivery windows, complex supply chain needs, or sequential outsourcing requirements for peptides, oligonucleotides, and POCs.

Awards and credibility Recent Forbes China Industry Development Leading Enterprise recognition for CPC Scientific and Medtide Inc. enhances credibility and visibility. Use this cred in outreach to reassure prospective customers about reliability, quality, and financial backing for long-duration, capital-intensive programs.

Regulatory and compliance proficiency Strong CGMP, FDA/ICH adherence, and comprehensive regulatory support for IND, NDA, BLA and API filings position CPC Scientific as a risk-reducing partner. Sales opportunities exist with companies seeking experienced CRO-CDMO partners to navigate regulatory pathways efficiently and secure timely approvals.